Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Market Cap

Sangamo Therapeutics has a market cap or net worth of $145.94 million as of January 2, 2026. Its market cap has decreased by -65.88% in one year.

• Market Cap: 145.94M
• Enterprise Value: 133.80M
• 1-Year Change: -65.88%
• Ranking: #4005
• Category: Micro-Cap
• Stock Price: $0.43

Market Cap Chart

Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $145.94M, a decrease of -53.54%. That is a compound annual growth rate of -2.93%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2025	141.30M	-33.60%
Dec 31, 2024	212.80M	120.98%
Dec 29, 2023	96.30M	-81.29%
Dec 30, 2022	514.60M	-52.90%
Dec 31, 2021	1.09B	-50.50%
Dec 31, 2020	2.21B	127.45%
Dec 31, 2019	970.40M	-17.20%
Dec 31, 2018	1.17B	-15.45%
Dec 29, 2017	1.39B	543.50%
Dec 30, 2016	215.40M	-66.32%
Dec 31, 2015	639.50M	-38.53%
Dec 31, 2014	1.04B	21.20%
Dec 31, 2013	858.40M	169.51%
Dec 31, 2012	318.50M	113.76%
Dec 30, 2011	149.00M	-50.38%
Dec 31, 2010	300.30M	12.98%
Dec 31, 2009	265.80M	86.40%
Dec 31, 2008	142.60M	-72.71%
Dec 31, 2007	522.60M	133.30%
Dec 29, 2006	224.00M	118.75%
Dec 30, 2005	102.40M	-32.23%
Dec 31, 2004	151.10M	11.35%
Dec 31, 2003	135.70M	83.13%
Dec 31, 2002	74.10M	-67.54%
Dec 31, 2001	228.30M	-47.02%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	962.25B
Johnson & Johnson	498.60B
AbbVie	403.83B
UnitedHealth Group	299.03B
AstraZeneca	287.81B
Novartis AG	266.00B
Merck & Co.	261.26B
Novo Nordisk	227.63B